Stock Market News

Raymond James and Guggenheim Stay Bullish on Alumis (ALMS) After Trial Results

wcc wcc
Apr 08, 2026 - 08:10
0 1
Raymond James and Guggenheim Stay Bullish on Alumis (ALMS) After Trial Results
Previous Article

Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX)

Next Article

Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Here are the Compelling Reasons to Own Visa (V)

Here are the Compelling Reasons to Own Visa (V)

wcc
Jul 24, 2026
0
1

Allianz to buy HSBC’s Singapore insurance unit for $...

wcc
Jul 24, 2026
0
1
What Makes Thermo Fisher Scientific (TMO) an Attractive Long-Term Bet?

What Makes Thermo Fisher Scientific (TMO) an Attract...

wcc
Jul 24, 2026
0
1
AI Worries Weighed on Jack Henry (JKHY) in Q2

AI Worries Weighed on Jack Henry (JKHY) in Q2

wcc
Jul 24, 2026
0
1
Wedbush Delivers Bold Verdict on Intel Stock Ahead of Earnings

Wedbush Delivers Bold Verdict on Intel Stock Ahead o...

wcc
Jul 24, 2026
0
1
Ares Management's Q2 2026 Earnings: What to Expect

Ares Management's Q2 2026 Earnings: What to Expect

wcc
Jul 24, 2026
0
1

Comments (0)

User